Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer: A time for reassessment?

Chest

Volumn 117, Issue 4 SUPPL. 1, 2000, Pages 119S-122S

  Bunn Jr , Paul A ^a   Mault, James ^a   Kelly, Karen ^a  

^a UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

Adjuvant therapy; Cisplatin; Lymph nodes; Neoadjuvant therapy; Non small cell lung cancer; Radiotherapy; Recurrence

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; NAVELBINE; PACLITAXEL;

CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK;

EID: 0342803682     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1998. CA Cancer J Clin 1998:48:6-9
2. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710-1717
3. Mountain CF, McMurtrey MJ, Frazier OH. Current results of surgical treatment for lung cancer. Cancer Bull 1980; 32:105-108
4. Thomas P, Rubinstein L. The Lung Cancer Study Group: cancer recurrence after resection; T1N0 non-small cell lung cancer. Ann Thorac Surg 1990; 49:242-247
5. Bunn P, Kelly K. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions. Clin Cancer Res 1998; 5:1087-1100
6. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111:1718-1723
7. The American Society of Clinical Oncology. Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer. J Clin Oncol 1997; 15:2996-3018
8. Mcloud TC, Bourgouin PU, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182:319-323
9. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995; 311:899-909
10. Wagner H Jr, Lad T, Piantadosi S. Randomized phase II evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin C, vinblastine, and cisplatin in patients with technically unresectable stage IIIA and IIIB non-small cell lung cancer. LCSG 881. Chest 1994; 106(suppl):348S-354S
11. The Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 1986; 315:1377-1381
12. Stewart LA, Burdett S, Souhami RL. Postoperative radiotherapy (PORT) in non-small cell lung cancer (NSCLC): a meta-analysis using individual patient data (IPD) from randomised clinical trials (RCTS). MRC cancer trials office, Cambridge, UK. University College London Medical School, London, UK [abstract 1760]. Proc Am Soc Clin Oncol 1999; 17:457A
13. Yellan SG, Cella DF. Someone to live for: social well being, parenthood states, and decision making in oncology. J Clin Oncol 1995; 13:1255-1264
14. Crook A, Duffy A, Girling DJ. Survey on the treatment of non-small cell lung cancer in England and Wales [abstract]. Lung Cancer 1997; 18(suppl1):9
15. Schaake-Koning C, Van Den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992; 326: 524-530
16. Martini N, Kris MG, Gralla RJ. The effects of pre-operative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal node metastases. Ann Thorac Surg 1988; 45:370-379
17. Rosell R, Gomez-Cordina J, Comps R, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994; 330:153-158
18. Roth JA, Fossella F, Kamoki R, et al. A randomized trial comparing preoperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 1994; 86:673-680
19. Roth JA, Atkinson EN, Fossella F, et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 1998; 21:1-6
20. Pass HI, Pogrebniak HW, Steinberg SM, et al. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 1992; 53:992-998
21. Pisters R, Kris M, Ginsberg J, et al. Induction paclitaxel & carboplatin (PC) in early stage non-small cell lung cancer (NSCLC): early results of a completed phase II trial [abstract 1800]. Proc Am Soc Clin Oncol 1999; 18:467A